publication . Article . 2017

Glucocorticoid induced osteoporosis in neurological patients: prevention and treatment

K. V. Antonova; N. A. Suponeva; N. I. Shcherbakova; D. A. Grishina; N. V. Belova; L. V. Kononova;
Open Access
  • Published: 01 Sep 2017 Journal: Neuromuscular Diseases, volume 7, pages 10-20 (issn: 2222-8721, eissn: 2413-0443, Copyright policy)
  • Publisher: Publishing House ABV Press
Glucocorticoids (GCs) are often prescribed for neurologic patients. Autoimmune diseases of central and peripheral nervous system, neuromuscular disorders are associated with disability and life-threatening complications, and require long-term high-dosage administration of GCs. GC-therapy is a crucial decision to be made by a neurologist in collaboration with a patient, and requires strict observance of clear guidelines on the prevention, diagnosis and treatment of possible complications. One of the most frequent complications of GCs is osteoporosis. According to the Russian and international guidelines, all the patients must undergo preliminary and follow-up lab...
Persistent Identifiers
free text keywords: glucocorticosteroids, osteoporotic fracture, bone mineral density, vitamin d, calcium, multiple sclerosis, myasthenia, chronic inflammatory demyelinating polyradiculoneuropathy, polymyositis, Glucocorticoid, medicine.drug, medicine, Bioinformatics, business.industry, business, Osteoporosis, medicine.disease, lcsh:Neurology. Diseases of the nervous system, lcsh:RC346-429
Any information missing or wrong?Report an Issue